NANPING, China, Dec. 7, 2020 /PRNewswire/ -- Happiness Biotech
Group Limited (the "Company" or Nasdaq: HAPP), an innovative
China-based nutraceutical and
dietary supplements producer, announced today that Happy Buy, the
Company's wholly-owned subsidiary focusing on e-commerce business,
has recorded over $3 million sales
since this November.
Currently Happy Buy carries out a variety of sales models,
including supplying our products to various online distributors on
major Chinese e-commerce platform; community e-commerce, e-commerce
livestreaming - mainly on Douyin (Chinese version of Tik-Tok),
Internet advertising and marketing services, etc. Through the
cooperation of other merchants such as Hive-Box, Multi-Channel
Network (MCN) companies and social media influencers, etc., Happy
Buy managed to realize incredible results quickly.
"We are very proud of the sales of Happy Buy, especially as a
new business segment just established in this September. After our
one-month's preparation in October, we achieved more than
$3 million in sales since this
November. What's more exciting is that even though the "11.11"
shopping festival in China has
ended, our e-commerce business is still growing at a high speed.
For the past month, Happy Buy's single-day sales has constantly
reached new highs. Therefore, we believe it is possible that we
will achieve our goal of over $20
million in sales from our e-commerce business by the end of
this fiscal year on March 31, 2021.
In the future, e-commerce will definitely become a crucial part of
Happiness Biotech." said Mr. Xuezhu
Wang, CEO of the Company.
About Happiness Biotech Group Limited
Headquartered in Nanping, China, Happiness Biotech Group Limited is an
innovative China-based
nutraceutical and dietary supplements producer focused on the
research, development, manufacturing and marketing of a variety of
products made from Chinese herbal extracts and other ingredients.
The Company's goal is to provide high-quality products to our
consumers. Over the past 14 years, the Company has established a
product portfolio consisting of 32 PRC National Medical Products
Administration registered "Blue-Cap" SKUs of nutraceutical and
dietary supplements products. For more information, please
visit: www.happ.org.cn.
Forward-Looking Statements
This press release contains forward-looking statements as
defined by the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include statements concerning plans,
objectives, goals, strategies, future events or performance, and
underlying assumptions and other statements that are other than
statements of historical facts. When the Company uses words such as
"may, "will, "intend," "should," "believe," "expect," "anticipate,"
"project," "estimate" or similar expressions that do not relate
solely to historical matters, it is making forward-looking
statements. Forward-looking statements are not guarantees of future
performance and involve risks and uncertainties that may cause the
actual results to differ materially from the Company's expectations
discussed in the forward-looking statements. These statements are
subject to uncertainties and risks including, but not limited to,
the following: the Company's goals and strategies; the
Company's future business development; product and service demand
and acceptance; changes in technology; economic conditions;
reputation and brand; the impact of competition and pricing;
government regulations; fluctuations in general economic and
business conditions in China, the
COVID-19 outbreak and its impact on our operations and assumptions
underlying or related to any of the foregoing and other risks
contained in reports filed by the Company with the Securities and
Exchange Commission. For these reasons, among others,
investors are cautioned not to place undue reliance upon any
forward-looking statements in this press release. Additional
factors are discussed in the Company's filings with the U.S.
Securities and Exchange Commission, which are available for review
at www.sec.gov. The Company undertakes no obligation to publicly
revise these forward-looking statements to reflect events or
circumstances that arise after the date hereof.
View original
content:http://www.prnewswire.com/news-releases/happiness-biotech-provides-sales-update-e-commerce-business-of-over-3-million-since-november-301187098.html
SOURCE Happiness Biotech Group Limited